|
|
|
|
|
|
|
|
|
|
"These data show that cisplatin resistance in HGS (high grade serous) carcinoma develops from pre-existing minor clones but that enrichment for these clones is not apparent during short-term chemotherapy treatment
Tuesday, June 29, 2010
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma - jnl Oncogene
"These data show that cisplatin resistance in HGS (high grade serous) carcinoma develops from pre-existing minor clones but that enrichment for these clones is not apparent during short-term chemotherapy treatment
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.